Cargando…

Patient Perspective on Iron Chelation Therapy: Barriers and Facilitators of Medication Adherence

Nonadherence to iron chelation therapy (ICT) remains a long-standing and serious issue in thalassemia, especially in resource-constrained developing countries. Barriers and facilitators of adherence to ICT in transfusion-dependent thalassemia (TDT) adult patients in Malaysia are not completely under...

Descripción completa

Detalles Bibliográficos
Autores principales: Chong, Chia Chee, Redzuan, Adyani Md, Sathar, Jameela, Makmor-Bakry, Mohd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205330/
https://www.ncbi.nlm.nih.gov/pubmed/34179377
http://dx.doi.org/10.1177/2374373521996958
_version_ 1783708487735312384
author Chong, Chia Chee
Redzuan, Adyani Md
Sathar, Jameela
Makmor-Bakry, Mohd
author_facet Chong, Chia Chee
Redzuan, Adyani Md
Sathar, Jameela
Makmor-Bakry, Mohd
author_sort Chong, Chia Chee
collection PubMed
description Nonadherence to iron chelation therapy (ICT) remains a long-standing and serious issue in thalassemia, especially in resource-constrained developing countries. Barriers and facilitators of adherence to ICT in transfusion-dependent thalassemia (TDT) adult patients in Malaysia are not completely understood. This qualitative study explored factors affecting adherence to ICT among TDT adult patients at a public tertiary hospital in Malaysia. Data were collected through 21 semistructured in-depth interviews conducted among purposively sampled patients using a pretested interview guide. All interviews were audio-recorded and transcribed verbatim. Data were analyzed manually using thematic analysis method and managed using Atlas.Ti software. The most frequently discussed subthemes of barriers to adherence included patient-related factors, medications-related factors, sociocultural-related factors, environmental context and resources, and patient–health care provider relationship factors. The facilitators to adherence included having insights of their illness, prevailing sources of motivation emphasizing on strong self-efficacy, low medication burden, and having enabling environment. This study has identified barriers and facilitators that are unique to Malaysian thalassemic adults related to medication adherence. Options for future multifaceted interventions are suggested.
format Online
Article
Text
id pubmed-8205330
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-82053302021-06-25 Patient Perspective on Iron Chelation Therapy: Barriers and Facilitators of Medication Adherence Chong, Chia Chee Redzuan, Adyani Md Sathar, Jameela Makmor-Bakry, Mohd J Patient Exp Research Article Nonadherence to iron chelation therapy (ICT) remains a long-standing and serious issue in thalassemia, especially in resource-constrained developing countries. Barriers and facilitators of adherence to ICT in transfusion-dependent thalassemia (TDT) adult patients in Malaysia are not completely understood. This qualitative study explored factors affecting adherence to ICT among TDT adult patients at a public tertiary hospital in Malaysia. Data were collected through 21 semistructured in-depth interviews conducted among purposively sampled patients using a pretested interview guide. All interviews were audio-recorded and transcribed verbatim. Data were analyzed manually using thematic analysis method and managed using Atlas.Ti software. The most frequently discussed subthemes of barriers to adherence included patient-related factors, medications-related factors, sociocultural-related factors, environmental context and resources, and patient–health care provider relationship factors. The facilitators to adherence included having insights of their illness, prevailing sources of motivation emphasizing on strong self-efficacy, low medication burden, and having enabling environment. This study has identified barriers and facilitators that are unique to Malaysian thalassemic adults related to medication adherence. Options for future multifaceted interventions are suggested. SAGE Publications 2021-03-03 /pmc/articles/PMC8205330/ /pubmed/34179377 http://dx.doi.org/10.1177/2374373521996958 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Research Article
Chong, Chia Chee
Redzuan, Adyani Md
Sathar, Jameela
Makmor-Bakry, Mohd
Patient Perspective on Iron Chelation Therapy: Barriers and Facilitators of Medication Adherence
title Patient Perspective on Iron Chelation Therapy: Barriers and Facilitators of Medication Adherence
title_full Patient Perspective on Iron Chelation Therapy: Barriers and Facilitators of Medication Adherence
title_fullStr Patient Perspective on Iron Chelation Therapy: Barriers and Facilitators of Medication Adherence
title_full_unstemmed Patient Perspective on Iron Chelation Therapy: Barriers and Facilitators of Medication Adherence
title_short Patient Perspective on Iron Chelation Therapy: Barriers and Facilitators of Medication Adherence
title_sort patient perspective on iron chelation therapy: barriers and facilitators of medication adherence
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205330/
https://www.ncbi.nlm.nih.gov/pubmed/34179377
http://dx.doi.org/10.1177/2374373521996958
work_keys_str_mv AT chongchiachee patientperspectiveonironchelationtherapybarriersandfacilitatorsofmedicationadherence
AT redzuanadyanimd patientperspectiveonironchelationtherapybarriersandfacilitatorsofmedicationadherence
AT satharjameela patientperspectiveonironchelationtherapybarriersandfacilitatorsofmedicationadherence
AT makmorbakrymohd patientperspectiveonironchelationtherapybarriersandfacilitatorsofmedicationadherence